- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04102748
Evaluation of Esthetic Outcomes of M-shaped Flap Implant Uncovering Technique Versus I-shaped Incision Around Single Implants in the Anterior Maxilla Using Pink Esthetic Score
September 23, 2019 updated by: Ahmed Ezzat Mousa, Cairo University
Evaluation of Esthetic Outcomes of M-flap Implant Uncovering Technique Versus I-shaped Incision Around Single Implants in the Anterior Maxilla Using Pink Esthetic Score (PES) (RCT)
The aim of this study is to evaluate the soft-tissue profile around a single-tooth implant in the anterior maxilla utilizing the PES after implant uncovering using "M" flap versus I-shaped incision.The primary objective is evaluation of esthetic outcomes around implant using PES.
Hypothesis: The use of I-shaped incision exposure technique will result in better esthetic outcomes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with osseointegrated dental implant in the anterior maxilla.
- Patients of 20 - 50 years
- Periodontally healthy patients.
- No intraoral soft and hard tissue pathology.
- No systemic condition that contraindicate surgical intervention.
Exclusion Criteria:
- Intraoral soft and hard tissue pathology.
- Heavy smokers more than 20 cigarettes per day.
- Patients with systemic disease that may affect normal healing.
- Psychiatric problems.
- Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conventional
|
Implant uncovering in the second stage using 3 different exposure techniques
|
|
Active Comparator: I-incision
|
Implant uncovering in the second stage using 3 different exposure techniques
|
|
Active Comparator: M-flap
|
Implant uncovering in the second stage using 3 different exposure techniques
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PES
Time Frame: 3 months
|
Esthetic outcomes around implant
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Anticipated)
March 15, 2020
Study Completion (Anticipated)
March 30, 2020
Study Registration Dates
First Submitted
September 21, 2019
First Submitted That Met QC Criteria
September 23, 2019
First Posted (Actual)
September 25, 2019
Study Record Updates
Last Update Posted (Actual)
September 25, 2019
Last Update Submitted That Met QC Criteria
September 23, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- Ezzat Implant Master Thesis
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Implant Failed
-
Istanbul Medipol University HospitalCompletedDental Implant Failed | Osseointegration Failure of Dental ImplantTurkey
-
Kafrelsheikh UniversityCompletedDental Implant Failed | Implant ComplicationEgypt
-
University of Sao PauloCompletedDental Implant Failed | Pre-osseointegration Failure of Dental ImplantBrazil
-
Kafrelsheikh UniversityRecruiting
-
University of BernITI International Team for Implantology, SwitzerlandRecruitingDental Implant FailedBrazil
-
G. d'Annunzio UniversityCompleted
-
Shanghai Ninth People's Hospital Affiliated to...Completed
-
Mohamed tarek mohamed youssif omarCairo UniversityUnknown
-
Cairo UniversityNot yet recruitingDental Implant Failed | Implant Site Reaction
-
Universitat Internacional de CatalunyaRecruitingDental Implant FailedSpain
Clinical Trials on I-incision, M-flap and conventional implant exposure techniques
-
Mansoura UniversityCompletedProsthesis DurabilityEgypt
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMalignant GliomaUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingRecurrent Endometrial Carcinoma | Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent... and other conditionsUnited States
-
Fudan UniversityRecruitingLocally Recurrent Rectal CancerChina
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Ganglioneuroblastoma, NodularUnited States, Australia, Canada, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedEwing Sarcoma of Bone | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMyxoid Liposarcoma | Synovial Sarcoma | Round Cell LiposarcomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingNeuroblastoma | Ganglioneuroblastoma | Ganglioneuroblastoma, NodularUnited States, Canada, Puerto Rico
-
Mayo ClinicNot yet recruitingHematopoietic and Lymphatic System NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States